156 related articles for article (PubMed ID: 31404235)
1. Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy.
Wang ZZ; Zhang YF; Huang WC; Wang XP; Ni XJ; Lu HY; Hu JQ; Deng SH; Zhu XQ; Xie HS; Chen HZ; Zhang M; Qiu C; Wen YG; Shang DW
Front Pharmacol; 2019; 10():832. PubMed ID: 31404235
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
3. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
[TBL] [Abstract][Full Text] [Related]
4. A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy.
Chen Y; Xu S; Wang Z; Zhao M; Wang H; Lu T; Zhao L
Ther Drug Monit; 2018 Dec; 40(6):730-737. PubMed ID: 30169477
[TBL] [Abstract][Full Text] [Related]
5. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
6. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy.
Baldoni AO; Freitas-Lima P; de Santi Ferreira FI; Martinez EZ; Queiroz RH; Sakamoto AC; Alexandre V; Perucca E; Pereira LR
Clin Exp Pharmacol Physiol; 2016 Jul; 43(7):685-9. PubMed ID: 27120710
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
[TBL] [Abstract][Full Text] [Related]
9. Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy.
Shen CH; Zhang YX; Lu RY; Jin B; Wang S; Liu ZR; Tang YL; Ding MP
Epilepsy Res; 2016 Nov; 127():186-190. PubMed ID: 27610747
[TBL] [Abstract][Full Text] [Related]
10. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy.
Zhang ZB; Ji SM; Han Y; Zang LL; Wang YH; Lu W; Wang L; Wu Y
Eur J Clin Pharmacol; 2017 Apr; 73(4):445-453. PubMed ID: 28064355
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of lamotrigine in Indian epileptic patients.
Mallaysamy S; Johnson MG; Rao PG; Rajakannan T; Bathala L; Arumugam K; van Hasselt JG; Ramakrishna D
Eur J Clin Pharmacol; 2013 Jan; 69(1):43-52. PubMed ID: 22660444
[TBL] [Abstract][Full Text] [Related]
13. UGT polymorphisms and lamotrigine clearance during pregnancy.
Petrenaite V; Öhman I; Ekström L; Sæbye D; Hansen TF; Tomson T; Sabers A
Epilepsy Res; 2018 Feb; 140():199-208. PubMed ID: 29395496
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine pharmacokinetics following oral and stable-labeled intravenous administration in young and elderly adult epilepsy patients: Effect of age.
Polepally AR; Brundage RC; Remmel RP; Leppik IE; Pennell PB; White JR; Ramsay RE; Kistner BM; Birnbaum AK
Epilepsia; 2018 Sep; 59(9):1718-1726. PubMed ID: 30101556
[TBL] [Abstract][Full Text] [Related]
15. Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy.
Ortega-Vázquez A; Fricke-Galindo I; Dorado P; Jung-Cook H; Martínez-Juárez IE; Monroy-Jaramillo N; Rojas-Tomé IS; Peñas-Lledó E; Llerena A; López-López M
Pharmacogenomics J; 2020 Dec; 20(6):845-856. PubMed ID: 32483200
[TBL] [Abstract][Full Text] [Related]
16. [Population pharmacokinetics of lamotrigine in Chinese children with epilepsy].
Zhang S; Wang L; Lu W
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):105-9. PubMed ID: 18433522
[TBL] [Abstract][Full Text] [Related]
17. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response.
Bartoli A; Guerrini R; Belmonte A; Alessandrì MG; Gatti G; Perucca E
Ther Drug Monit; 1997 Jun; 19(3):252-60. PubMed ID: 9200763
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between UGT1A4 142T>G polymorphism and serum concentration of lamotrigine in Chinese epileptic patients: a meta-analysis].
Li Z; Wang Y
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(41):3365-3370. PubMed ID: 30440130
[No Abstract] [Full Text] [Related]
19. Lamotrigine clearance increases by 5 weeks gestational age: Relationship to estradiol concentrations and gestational age.
Karanam A; Pennell PB; French JA; Harden CL; Allien S; Lau C; Barnard S; Callisto SP; Birnbaum AK
Ann Neurol; 2018 Oct; 84(4):556-563. PubMed ID: 30168175
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral contraceptives on lamotrigine levels depends on comedication.
Wegner I; Wilhelm AJ; Lambrechts DA; Sander JW; Lindhout D
Acta Neurol Scand; 2014 Jun; 129(6):393-8. PubMed ID: 24571554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
